ZA942131B - Pyridothiadiazines processes for their preparation and the pharmaceutical compositions which contain them - Google Patents

Pyridothiadiazines processes for their preparation and the pharmaceutical compositions which contain them

Info

Publication number
ZA942131B
ZA942131B ZA942131A ZA942131A ZA942131B ZA 942131 B ZA942131 B ZA 942131B ZA 942131 A ZA942131 A ZA 942131A ZA 942131 A ZA942131 A ZA 942131A ZA 942131 B ZA942131 B ZA 942131B
Authority
ZA
South Africa
Prior art keywords
pyridothiadiazines
contain
processes
preparation
pharmaceutical compositions
Prior art date
Application number
ZA942131A
Other languages
English (en)
Inventor
Bernard Pirotte
Pascal De Tullio
Bernard Masereel
Jacques Delarge
Jean Lepagnol
Pierre Renard
Original Assignee
Adir
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Adir filed Critical Adir
Publication of ZA942131B publication Critical patent/ZA942131B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
ZA942131A 1993-03-26 1994-03-25 Pyridothiadiazines processes for their preparation and the pharmaceutical compositions which contain them ZA942131B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9303458A FR2703051B1 (fr) 1993-03-26 1993-03-26 Nouvelles pyridothiadiazines, leurs procédés de préparation, et les compositions pharmaceutiques qui les contiennent.

Publications (1)

Publication Number Publication Date
ZA942131B true ZA942131B (en) 1995-04-05

Family

ID=9445338

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA942131A ZA942131B (en) 1993-03-26 1994-03-25 Pyridothiadiazines processes for their preparation and the pharmaceutical compositions which contain them

Country Status (13)

Country Link
US (1) US5459138A (de)
EP (1) EP0618209B1 (de)
JP (1) JP2513989B2 (de)
AT (1) ATE174920T1 (de)
AU (1) AU673893B2 (de)
CA (1) CA2119853C (de)
DE (1) DE69415373T2 (de)
DK (1) DK0618209T3 (de)
ES (1) ES2128519T3 (de)
FR (1) FR2703051B1 (de)
GR (1) GR3029406T3 (de)
NZ (1) NZ260186A (de)
ZA (1) ZA942131B (de)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5488056A (en) * 1994-10-31 1996-01-30 Eli Lilly And Company Method for treating anxiety
JP3117725B2 (ja) * 1995-11-15 2000-12-18 山之内製薬株式会社 カイニン酸神経細胞毒性阻害剤及びピリドチアジン誘導体
US6225310B1 (en) 1996-01-17 2001-05-01 Novo Nordisk A/S Fused 1,2,4-thiadiazine derivatives, their preparation and use
CZ220498A3 (cs) * 1996-01-17 1998-11-11 Novo Nordisk A/S Deriváty 1,2,4-thiadiazinu a 1,4-thiazinu, příprava a použití
CZ220598A3 (cs) * 1996-01-17 1998-12-16 Novo Nordisk A/S Deriváty pyrido-1,2,4-thiadiazinu, jejich příprava a použití
WO1997039750A1 (en) * 1996-04-19 1997-10-30 The Regents Of The University Of California Treatment of mood/affective disorders by glutamatergic upmodulators
TR199800906T1 (xx) * 1996-09-24 2000-02-21 Dow Agrosciences Llc N-($1,2,4]Triazoloazinil ) benzens�lfonamid ve piridins�lfonamid bile�ikleri ve bunlar�n herbisidler olarak kullan�mlar�
US6329368B1 (en) * 1997-05-09 2001-12-11 The Regents Of The University Of California Endocrine modulation with positive modulators of AMPA type glutamate receptors
EP1000066A1 (de) * 1997-07-16 2000-05-17 Novo Nordisk A/S Kondensierte 1,2,4-thiadiazinderivate, ihre herstellung und verwendung
WO1999032495A1 (en) * 1997-12-19 1999-07-01 Novo Nordisk A/S Pyrido 1,2,4-thiadiazine derivatives, their preparation and use
DE19824232A1 (de) * 1998-05-29 1999-12-02 Bayer Ag Pyridodithiazindioxide
DE19918021C1 (de) 1999-04-21 2000-06-29 Ruetgers Organics Gmbh Verfahren zur Herstellung von chlorierten Pyridinsulfonsäurechloriden
EP1194430A1 (de) * 1999-06-30 2002-04-10 Novo Nordisk A/S Verfahren
SK14802002A3 (sk) 2000-03-20 2003-05-02 Teva Pharmaceutical Industries Ltd. Nový spôsob prípravy medziproduktu torsemidu
WO2002000665A1 (en) * 2000-06-26 2002-01-03 Novo Nordisk A/S Use of potassium channel openers for the treatment of insulitis
AU2002307327A1 (en) * 2001-05-04 2002-11-18 Eli Lilly And Company Use of an ampa receptor potentiator for the manufacture of a medicament for the treatment of type 2 diabetes
US7902203B2 (en) 2002-11-01 2011-03-08 Abbott Laboratories, Inc. Anti-infective agents
US7378414B2 (en) 2003-08-25 2008-05-27 Abbott Laboratories Anti-infective agents
US7492956B2 (en) * 2004-08-18 2009-02-17 Cisco Technology, Inc. Video coding using multi-dimensional amplitude coding and 2-D non-zero/zero cluster position coding
CN104958270A (zh) 2004-08-25 2015-10-07 伊森舍丽斯有限公司 钾atp通道开放剂的药物制剂及其应用
WO2006093801A1 (en) * 2005-02-25 2006-09-08 Abbott Laboratories Thiadiazine derivatives useful as anti-infective agents
EP1777219A1 (de) * 2005-10-20 2007-04-25 Faust Pharmaceuticals 1,2-Substituierte-Naphthalen-Derivate mit antiglutamatergen Eigenschaften und deren Verwendungen
PL1968601T3 (pl) * 2006-01-05 2012-03-30 Essentialis Inc Sole związków otwierających kanały potasowe ATP i ich zastosowanie
CN100393726C (zh) * 2006-04-20 2008-06-11 山东大学 2,4-二取代杂环并[4,5-e][1,2,4]噻二嗪衍生物制备方法
CN110054647B (zh) * 2019-05-23 2021-06-15 上海勋和医药科技有限公司 托拉塞米磷酸酯类前药、其制备方法及组合物
AU2020372712A1 (en) * 2019-10-30 2022-06-16 Janssen Sciences Ireland Unlimited Company Synthesis of 3-nitro-N-(2,2,2-trifluoroethyl)-4-pyridinamine

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3157647A (en) * 1960-10-31 1964-11-17 Olin Mathieson Process for producing nu-alkyl and nu-aralkyl thiadiazine compounds
US3288678A (en) * 1963-09-12 1966-11-29 Ciba Geigy Corp Diuretic compositions
GB1368948A (en) * 1970-11-11 1974-10-02 Manuf Prod Pharma Pyridine derivatives
JPS5854158B2 (ja) * 1975-10-02 1983-12-02 ヒサミツセイヤク カブシキガイシヤ シンキナピリドチアジアジンユウドウタイノセイゾウホウ

Also Published As

Publication number Publication date
EP0618209B1 (de) 1998-12-23
DK0618209T3 (da) 1999-08-23
EP0618209A1 (de) 1994-10-05
JPH072872A (ja) 1995-01-06
CA2119853C (fr) 2002-09-10
ES2128519T3 (es) 1999-05-16
AU5904894A (en) 1994-09-29
NZ260186A (en) 1995-07-26
ATE174920T1 (de) 1999-01-15
FR2703051B1 (fr) 1995-04-28
US5459138A (en) 1995-10-17
GR3029406T3 (en) 1999-05-28
JP2513989B2 (ja) 1996-07-10
DE69415373T2 (de) 1999-08-26
AU673893B2 (en) 1996-11-28
FR2703051A1 (fr) 1994-09-30
CA2119853A1 (fr) 1994-09-27
DE69415373D1 (de) 1999-02-04

Similar Documents

Publication Publication Date Title
GR3029406T3 (en) Pyridothiadiazines, processes for their preparation and pharmaceutical compositions containing them.
ZA926328B (en) Naphthylethylureas and naphthylethylthioureas process for the preparation thereof and pharmaceutical compositions containing them.
IL101819A0 (en) Amidinophenylalanine derivatives,a process for the preparation thereof,use thereof and agents containing these as anticoagulants
ZA935276B (en) 3-(hydroxybenzylidenyl)-indolin-2-ones processes for their preparation and pharmaceutical compositions containing them
GR3018212T3 (en) Naphtylalkylamines, process for their preparation and pharmaceutical compositions containing them.
IL108571A0 (en) Derivatives of quinolonecarboxylic acid and naphthyrdionecarboxylic acid, their preparation and pharmaceutical compositions containing them
AU642053B2 (en) Novel compounds of N-benzoylproline, process for their preparation and pharmaceutical compositions containing them
ZA944728B (en) alph -amino acid compounds a process for the preparation thereof and pharmaceutical compositions containing them
ZA932359B (en) 3-Aminochroman spiro compounds processes for preparing them and pharmaceutical compositions containing them
AU4861693A (en) New chromene compounds having a triene side chain, process for the preparation thereof, and pharmaceutical compositions containing them
AU6187394A (en) New pyrrolopyrazine compounds, processes for their preparation and the pharmaceutical compositions which contain them
AU679132B2 (en) New eburnane analogues, a process for the preparation thereof and pharmaceutical compositions containing them
ZA941196B (en) Angiopeptin cyclopeptide compounds process for the preparation thereof and pharmaceutical compositions containing them
FI903701A0 (fi) Reninhaemmande amino-oligohydroxiderivat.
HK27096A (en) Benzofuranylimidazole derivatives
IL104444A0 (en) Alpha-aryl-alpha-hydroxy-beta-imidazolinyl-propionamides,their preparation and pharmaceutical compositions containing them
GR3023939T3 (en) (Thia) cycloalkyl(b)indoles, process of their preparation and compositions containing it.
GR3021200T3 (en) (Cyclohexyl)-alken compounds, process for their preparation and pharmaceutical compositions containing them.
ZA933942B (en) Pyrrolothienopyrazine compounds, processes for the preparation thereof and pharmaceutical compositions containing them